XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
 1 Months Ended 12 Months Ended
Aug. 22, 2023
USD ($)
Oct. 06, 2022
USD ($)
Oct. 03, 2022
USD ($)
Mar. 31, 2021
USD ($)
Apr. 28, 2019
USD ($)
Jan. 04, 2018
USD ($)
$ / shares
shares
Jun. 30, 2012
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
 [2]
Dec. 31, 2023
ILS (₪)
Dec. 11, 2022
USD ($)
Dec. 11, 2022
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                          
Net sales royalty percenatge               3.00%          
Gross proceeds from cash fee percentage     7.00%                    
Gross proceeds from management fee percentage     1.00%                    
Stock issued during period, value, new issues               $ 6,558,000 [1] $ 4,324,000        
Joseph Mona [Member]                          
Loss Contingencies [Line Items]                          
Purchase price of plaintiffs $ 485,000     $ 485,000                  
Device [Member]                          
Loss Contingencies [Line Items]                          
Royalties percentage   3.00%                      
Integrated Product [Member]                          
Loss Contingencies [Line Items]                          
Royalties percentage   1.50%                      
Securities Purchase Agreement [Member]                          
Loss Contingencies [Line Items]                          
Purchase price of plaintiffs               6,750,000          
Israeli Innovation Authority [Member]                          
Loss Contingencies [Line Items]                          
Grants Receivable               304   ₪ 27,000 $ 83 ₪ 300,000  
[custom:AdditionalGrantReceivable-0]               $ 447   ₪ 1,620,000      
Israeli Innovation Authority [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Net sales royalty percenatge               3.00%          
Israeli Innovation Authority [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Net sales royalty percenatge               5.00%          
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                          
Loss Contingencies [Line Items]                          
Repayment of government grants           $ 530,000              
Israeli Innovation Authority [Member] | Nitiloop [Member]                          
Loss Contingencies [Line Items]                          
Repayment of government grants   $ 925,000                      
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Net sales royalty percenatge             1.50%            
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Net sales royalty percenatge             3.00%            
CardioSert Ltd [Member] | Technology [Member]                          
Loss Contingencies [Line Items]                          
Payment to acquire intangible assets           $ 300,000              
Number of common shares issued for acquisition | shares           6,738              
Number of common shares issued for acquisition, value           $ 74,000              
Buy back amount per patent | $ / shares           $ 1.00              
Consulting fee description           Additionally, the CardioSert Agreement may be terminated by either party upon breach of the other (subject to cure). Until May 2023, Microbot Israel paid CardioSert a monthly consultation fee of NIS              
Professional Fees           $ 40,000,000              
Monthly consultation fee in USD | $ / shares           $ 11              
Currency exchange rate, description           exchange rate of NIS 3.7 to the dollar)              
CardioSert Ltd [Member] | Minimum [Member] | Technology [Member]                          
Loss Contingencies [Line Items]                          
Investments           $ 2,000,000              
H.C. Wainwright & Co. LLC [Member]                          
Loss Contingencies [Line Items]                          
Professional Fees     $ 565,000                    
Warrant issued, descriptions     The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering.                    
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                          
Loss Contingencies [Line Items]                          
Offering costs                         $ 10,000,000
Stock issued during period, value, new issues   $ 8,000,000                      
Alliance Investment Management, Ltd. [Member]                          
Loss Contingencies [Line Items]                          
Litigation settlement         $ 468,000                
2013 Through June 30, 2022 [Member] | Israeli Innovation Authority [Member]                          
Loss Contingencies [Line Items]                          
Revenue from Contract with Customer, Including Assessed Tax               $ 1,804,000          
[1] Net of issuance costs in the amount of $1,075.
[2] Net of issuance costs in the amount of $676.